Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Microsoft's Q3 revenue grows 18% YoY, driven by Azure and SaaS, with strong AI prospects boosting buy rating.

Analyst Insights
13 May 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Microsoft reported an 18% year-over-year revenue increase in Q3, fueled by strong growth in its Azure cloud services and SaaS segments. The Productivity and Business Processes division grew 17%, countering concerns about AI disrupting SaaS demand and highlighting ongoing enterprise needs. Despite higher capital expenditures and some challenges, Microsoft's forward price-to-earnings ratio is near multiyear lows, making it an attractive investment opportunity. The analyst maintains a strong buy rating, citing overblown fears of SaaS decline and positive AI-driven growth prospects for long-term performance.

More News (MSFT)

AI chip maker Cerebras raises $5.55B in IPO, valued at $56.4B amid growing AI market interest.

AI chip maker Cerebras raises $5.55B in IPO, valued at $56.4B amid growing AI market interest.

Cerebras Systems, a company specializing in AI chips, raised at least $5.55 billion in its IPO, pricing shares at $185 each, above expectations. The IPO values the company at $56.4 billion and marks one of the largest tech IPOs in recent years. Cereb...

Market News
Bullish
8 hours ago
Microsoft CEO Nadella feared OpenAI would surpass Microsoft as early as April 2022.

Microsoft CEO Nadella feared OpenAI would surpass Microsoft as early as April 2022.

In a recent court case involving Elon Musk and Sam Altman, it was revealed that Microsoft CEO Satya Nadella was concerned as early as April 2022 that OpenAI might overtake Microsoft in the tech industry. Despite Microsoft's early investment and partn...

Market News
Neutral
9 hours ago
AI in life sciences market set to grow at 20% CAGR, reaching $11.5B by 2034 driven by drug discovery and data analytics.

AI in life sciences market set to grow at 20% CAGR, reaching $11.5B by 2034 driven by drug discovery and data analytics.

The global AI in life sciences market is projected to expand at a compound annual growth rate (CAGR) of about 20% from 2026 to 2034, reaching an estimated value of $11.5 billion. This growth is fueled by increasing demand for faster drug discovery, p...

Market News
Bullish
9 hours ago
Tech sector concentration hits 41%, raising risks similar to 2000 dot-com peak, warns Piper Sandler analyst.

Tech sector concentration hits 41%, raising risks similar to 2000 dot-com peak, warns Piper Sandler analyst.

Craig Johnson of Piper Sandler warns that the US tech sector now makes up 41% of investable assets, a level not seen since the 2000 dot-com bubble peak. This concentration is driven by a few mega-cap stocks like NVIDIA, Apple, and Microsoft, which to...

Technical Signals
Neutral
9 hours ago
Investors buy Oracle and Microsoft on AI growth despite recent stock drops and high spending.

Investors buy Oracle and Microsoft on AI growth despite recent stock drops and high spending.

Oracle and Microsoft, two leaders in enterprise software and AI infrastructure, have seen their stocks lag despite strong earnings and growth in AI-related revenue. Oracle faces concerns over high capital expenditures and debt but boasts a $553 billi...

Market News
Bullish
12 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App